title: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
abstract: Neoadjuvant (primary systemic) treatment has become a standard option for primary operable disease for patients who are candidates for adjuvant systemic chemotherapy, irrespective of the size of the tumor. Because of new treatments and new understandings of breast cancer, however, recommendations published in 2006 regarding neoadjuvant treatment for operable disease required updating. Therefore, a third international panel of representatives of a number of breast cancer clinical research groups was convened in September 2006 to update these recommendations. As part of this effort, data published to date were critically reviewed and indications for neoadjuvant treatment were newly defined.
authors.affiliation: J. W. Goethe-University, Frankfurt am Main, Germany. M.Kaufmann@em.uni-frankfurt.de
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
authors.forename: G
authors.initials: G
authors.lastname: von Minckwitz
authors.forename: H D
authors.initials: HD
authors.lastname: Bear
authors.forename: A
authors.initials: A
authors.lastname: Buzdar
authors.forename: P
authors.initials: P
authors.lastname: McGale
authors.forename: H
authors.initials: H
authors.lastname: Bonnefoi
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: C
authors.initials: C
authors.lastname: Denkert
authors.forename: W
authors.initials: W
authors.lastname: Eiermann
authors.forename: R
authors.initials: R
authors.lastname: Jackesz
authors.forename: A
authors.initials: A
authors.lastname: Makris
authors.forename: W
authors.initials: W
authors.lastname: Miller
authors.forename: J-Y
authors.initials: JY
authors.lastname: Pierga
authors.forename: V
authors.initials: V
authors.lastname: Semiglazov
authors.forename: A
authors.initials: A
authors.lastname: Schneeweiss
authors.forename: R
authors.initials: R
authors.lastname: Souchon
authors.forename: V
authors.initials: V
authors.lastname: Stearns
authors.forename: M
authors.initials: M
authors.lastname: Untch
authors.forename: S
authors.initials: S
authors.lastname: Loibl
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D020869:Gene Expression Profiling; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D000970:Antineoplastic Agents